LEQSELVI FDA approval date
The FDA approved LEQSELVI on 25 Jul 2024.
- FDA approval date
- 25 Jul 2024
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as DEURUXOLITINIB PHOSPHATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2024-07-25Day | LEQSELVI | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA217900", "applicant_as_listed_by_fda": "SUN PHARM INDS INC", "brand_names": ["LEQSELVI"], "active_ingredients": ["DEURUXOLITINIB PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20240725", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |